Literature DB >> 8899661

A comparison of three measures of disease progression in ALS.

P L Andres1, L M Skerry, B Thornell, L G Portney, L J Finison, T L Munsat.   

Abstract

Effective clinical trials in neuromuscular research require accurate and sensitive methods to quantitate disease progression. The purpose of this study was to concurrently compare manual muscle testing (MMT), maximal voluntary isometric contraction (MVIC), and a functional scale (the ALS Score). Twenty patients with ALS were tested ten times at monthly intervals using each of the three methods. High inter-rater reliability for each of the three methods was demonstrated. All three methods demonstrated a decline over the testing period. However, MMT and the ALS Score were less sensitive to early change. A wide variation of percent of normal MVIC was demonstrated within each MMT grade and extensive overlap between MMT grades was observed. MVIC is the method of choice in studying patients in the early stages of ALS and in studies conducted over a short period of time.

Entities:  

Mesh:

Year:  1996        PMID: 8899661     DOI: 10.1016/0022-510x(96)00108-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

Review 1.  Strength Testing in Motor Neuron Diseases.

Authors:  Jeremy M Shefner
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

2.  Outcome measures in amyotrophic lateral sclerosis clinical trials.

Authors:  Sabrina Paganoni; Merit Cudkowicz; James D Berry
Journal:  Clin Investig (Lond)       Date:  2014

3.  Clinical features of spinal and bulbar muscular atrophy.

Authors:  Lindsay E Rhodes; Brandi K Freeman; Sungyoung Auh; Angela D Kokkinis; Alison La Pean; Cheunju Chen; Tanya J Lehky; Joseph A Shrader; Ellen W Levy; Michael Harris-Love; Nicholas A Di Prospero; Kenneth H Fischbeck
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

Review 4.  Assessment of Motor Units in Neuromuscular Disease.

Authors:  Robert D Henderson; Pamela A McCombe
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

5.  An Objective Functional Characterisation of Head Movement Impairment in Individuals with Neck Muscle Weakness Due to Amyotrophic Lateral Sclerosis.

Authors:  Silvia Pancani; Wendy Tindale; Pamela J Shaw; Christopher J McDermott; Claudia Mazzà
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

Review 6.  Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials.

Authors:  Mehdi Ghasemi; Charles P Emerson; Lawrence J Hayward
Journal:  Cells       Date:  2022-02-16       Impact factor: 6.600

7.  SAFETY AND TOLERABILITY OF STRENGTH TRAINING IN SPINAL AND BULBAR MUSCULAR ATROPHY: A CASE REPORT.

Authors:  Vincent Shieh; Cris Zampieri; Paul Stout; Galen O Joe; Angela Kokkinis; Kenneth H Fischbeck; Christopher Grunseich; Joseph A Shrader
Journal:  J Rehabil Med Clin Commun       Date:  2022-08-18

8.  Assessment of precision and reproducibility of a new myograph.

Authors:  Niels Rahe-Meyer; Michael Winterhalter; Aminul I Ahmed; Christian Weilbach; Matthias Gross; Siegfried Piepenbrock; Matthias Pawlak
Journal:  Biomed Eng Online       Date:  2007-12-20       Impact factor: 2.819

Review 9.  Quantifying disease progression in amyotrophic lateral sclerosis.

Authors:  Neil G Simon; Martin R Turner; Steve Vucic; Ammar Al-Chalabi; Jeremy Shefner; Catherine Lomen-Hoerth; Matthew C Kiernan
Journal:  Ann Neurol       Date:  2014-09-30       Impact factor: 10.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.